loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20637 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CARMUSTINE (1)

filter

01 AZURITY (1)

filter

01 IMPLANT;INTRACRANIAL (1)

filter

01 7.7MG (1)

filter

01 USA (1)

URL Supplier Web Content
IMPLANT;INTRACRANIAL
7.7MG
GLIADEL
USA
20637
1996-09-23
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20637

Looking for CTD TGA MCC DOSSIER APPLICATION 20637 1

19

Azurity Pharma, based in U.S.A, is a pharmaceutical company.

One of their notable products is CARMUSTINE, with a corresponding application number 20637 and regulatory information .

proudly manufactured in the

approval since 1996-09-23

Azurity Pharma's GLIADEL IMPLANT;INTRACRANIAL, medication with 7.7MG of CARMUSTINE.

Post Enquiry
POST ENQUIRY